Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-label Trial of Metformin for Weight Control of Pediatric Patients on Atypical Antipsychotic Medications.

NCT00391261 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT00391261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-label Trial of Metformin for Weight Control of Pediatric Patients on Atypical Antipsychotic Medications.
Lead sponsor
Cambridge Health Alliance
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
October 31, 2007
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders, bipolar disorder, schizoaffective disorder, schizophrenia, schizophreniform disorder